Gene+ Email Formats

Biotechnology Research • Changping District, Beijing, China • 51-100 Employees

Gene+ Email Formats

Gene+ uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 48.2% of the time.

Format	Example	Percentage
{first name}.{last name}@company.com	john.doe@company.com	48.2%
{first name initial}{last name}@company.com	{first name initial}doe@company.com	24.1%
{first name}@company.com	john@company.com	12.4%
{last name}.{first name}@company.com	doe.john@company.com	8.9%
{first name}{last name}@company.com	johndoe@company.com	6.4%

Key Contacts at Gene+

Eric Chen

International Sales Director

涛刘

Bioinformatic Director

Daniel Wang

Marketing Director

Company overview

Headquarters	Building 6, PKU Medical Industrial Park, Zhongguancun Life Science Park, Changping District, Beijing, 102200, CN
Phone number	+861053955678
Websites	geneplus.cn geneplus.org.cn
NAICS	541714
Keywords	Genetic Testing, Molecular Diagnostics, Next-Generation Sequencing, Comprehensive Genomic Profiling
Founded	2015
Employees	51-100
Socials

About Gene+

Founded in 2015, Gene+ is a genetic testing and precision oncology company dedicated to the development and commercialization of next-generation sequencing products and services. Gene+ offers a range of comprehensive genomic profiling assays to identify the genetic alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials using fully automatic bioinformatic analysis, interpretation and report generating system. With its CAP-accredited, EMQN-accredited and ISO-accredited clinical laboratories, Gene+ has been able to serve its customers with the highest standards and best quality, accumulating more than 400,000 samples tested. Using big data platform of cancer genomics, Gene+ has developed a deep cooperation and connection with its partners ranging from biotechs, biopharmas to research institutes, including MD Anderson Cancer, Duke University, BeiGene, and AstraZeneca etc, with more than 400 collaboration projects in scientific research and clinical application and more than 230 publications in Science, Nature Genetics, Nature Medicine, etc. For more information, please visit our website at en.geneplus.cn or contact us at global.service@geneplus.org.cn.